Skip to main content
Tech.euFundingExplorerBeta

Cardea Bio

Exited

Cardea Bio is the world’s only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit).

Cardea Bio is tracked in the Tech.eu funding database. Based in San Diego, United States; active in Semiconductors. Acquired by Paragraf in 2023. Data as of 28 Oct 2026.

Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
May 2023
Value
—
Acquiror

Related news

Similar companies

same sector or country

Global coverage: FundingData